P&G Health News
AllNewsAnnouncementRecos
BSE LIVE
Change:
Volume:
Open:
Prv. Close:
Bid:
()
Offer:
()
NSE LIVE
Change:
Volume:
Open:
Prv. Close:
Bid:
()
Offer:
()
Procter & Gamble Health Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Heal...
| AnnouncementDear Sir,Please find attached communication in respect of deduction of TDS on final dividend, to be paid if approved by shareholder of the Company at the ensuing Annual General Meeting of the Company. Request you to kindly take the same on record.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,Please find attached intimation received from our shareholder regarding loss/misplacement of share certificate.Kindly take the same on records.
Procter & Gamble Health Compliances-Reg.24(A)-Annual Secretarial Compliance
| AnnouncementDear Sir,Please find attached the annual secretarial compliance report for the financial year ended June 30, 2024.
Procter & Gamble Health Intimation Of Book Closure
| AnnouncementWe would like to inform that the Register of Members and Share transfer books shall remain closed from November 29, 2024 to December 5, 2024 for the purpose of Annual General Meeting and payment of dividend for the Financial Year 2023-24, if approved by the shareholders of the Company at their 57th Annual General Meeting to be held on December 5, 2024. The notice of the Annual General Meeting will be shared in the due course.
Procter & Gamble Health Announcement under Regulation 30 (LODR)-Press Release / Media Release
| AnnouncementFind enclosed the press release on the financial results for the year ended June 30,2024
Procter & Gamble Health Corporate Action-Board approves Dividend
| AnnouncementWe are pleased to inform you that the Board at its meeting held today recommended a final dividend of Rs. 60 per equity share for the financial year ended June 30,2024
Procter & Gamble Health Financial Results For The Financial Year Ended June 30,2024
| AnnouncementEnclosed are the financial results for the financial year ended June 30,2024 along with the auditors report
Procter & Gamble Health Board Meeting Outcome for Audited Financial Results And Final Dividend
| AnnouncementWe are pleased to inform you that at the meeting of the Board of Directors of the Company heldtoday the Audited Financial Results for Financial Year ended June 30, 2024, were approved.Enclosing herewith : Results for the Financial Year ended June 30, 2024, as per format prescribedunder Regulation 33 of Securities Exchange Board of India (Listing Obligations and DisclosureRequirements), Regulations, 2015; Auditor's Report, in respect of the aforementioned Financial Results, as furnished by the Statutory Auditors of the Company; and A declaration with respect to Audit Report with unmodified opinion to the aforementioned Audited Financial Results.The Board of Directors of the Company at its meeting held today, inter alia, have recommended a final dividend of Rs. 60 per equity share, for the financial year ended June 30, 2024.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,We have been informed about loss/misplacement of share certificate by our shareholder, as detailed in enclosed letter.Request you to kindly take the same on record.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,We request you to kindly note that we have issued duplicate share certificate to our shareholder, as detailed in enclosed letter.Request you to kindly take note of the same.
Procter & Gamble Health Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
| AnnouncementFormat of Initial Disclosure to be made by an entity identified as a Large Corporate.
Sr. No. | Particulars | Details |
1 | Name of Company | Procter & Gamble Health Ltd |
2 | CIN NO. | L99999MH1967PLC013726 |
3 | Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) | 0.00 |
4 | Highest Credit Rating during the previous FY | 0 |
4a | Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4) | Not Applicable |
5 | Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the framework | BSE |
Designation: COMPANY SECRETARY
EmailId: [email protected]
Designation: CFO and Director
EmailId: [email protected]
Date: 31/07/2024
Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
Procter & Gamble Health Compliance Certificate Under Regulation 40(9) Of The SEBI (LODR) Regulations, 2015
| AnnouncementDear Sir,Please find enclosed certificate as issued by Company''s PCS confirming compliance as required under Regulation 40(9) of the SEBI (LODR) Regulations. Request you to kindly take note of the same.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,We have issued duplicate share certificate to our shareholder, as detailed in enclosed letter.Request you to kindly take note of the same.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,We have received intimation from our shareholder regarding loss/misplacement of share certificate, as detailed in enclosed letter. Kindly take the same on record.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,We have been informed by our shareholder regarding loss/misplacement of share certificate, as detailed in enclosed letter.Request you to kindly take note of the same.
Procter & Gamble Health Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
| AnnouncementDear Sir,Please find attached compliance certificate under Regulation 74(5) of the SEBI (DP) Participants Rules, for the quarter ended June 30, 2024. Kindly take the same into record.
Procter & Gamble Health Compliance Certificate For The Year Ended June 30, 2024
| AnnouncementDear Sir,Please find attached confirmation certificate signed by the Company and RTA for compliance done during the Financial year ended June 30, 2024.
Procter & Gamble Health Closure of Trading Window
| AnnouncementWe would like to inform you that the Trading Window of the Company shall remain closed from July 1, 2024 until 48 hours from the publication of the audited financial results for the financial year ended June 30, 2024, as further detailed in enclosed letter.
Procter & Gamble Health Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On August 21, 2024
| AnnouncementProcter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/08/2024 ,inter alia, to consider and approve In terms of Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, August 21, 2024, inter alia, to consider and approve Audited Financial Results and Statements for the Financial Year ended June 30, 2024 and to consider recommendation of dividend (if any).
Procter & Gamble Health Closure of Trading Window
| AnnouncementDear Sir,Please be informed that we have issued share certificate to our shareholder, as detailed in enclosed letter. Request you to kindly take note of the same.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementThere has been a typographical error in the share certificate details mentioned in the earlier announcement of even date, in this regard find enclosed revised details with respect to loss of share certificates of shareholders of the Company as intimated by the RTA, Kfin technologies Limited.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementFind enclosed details with respect to loss of share certificate(s) of shareholder(s) of the Company as intimated by the RTA, Kfin Technologies Limited.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementFind enclosed details with respect to loss of share certificate(s) of shareholder(s) of the Company as intimated by the RTA, Kfin Technologies Ltd.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,Please be informed that we have issued duplicate share certificate to our shareholder as per attached letter.Kindly take the same on record.
Procter & Gamble Health Announcement under Regulation 30 (LODR)-Press Release / Media Release
| AnnouncementFind enclosed press release on the unaudited financial results for the quarter ended March 31,2024
Procter & Gamble Health Quarter Ended March 31,2024
| AnnouncementEnclosed herewith are the unaudited financial results for the quarter ended March 31,2024 and the limited review report of the auditors thereon.
Procter & Gamble Health Board Meeting Outcome for Unaudited Financial Results For The Quarter Ended March 31,2024
| AnnouncementEnclosed herewith are the unaudited financial results for the quarter ended March 31,2024 along with the limited review report of the auditors thereon.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementFind enclosed details with respect to loss of share certificate(s) of shareholder(s) of the Company
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,We have received intimation from our shareholder regarding loss of share certificate, as detailed in enclosed letter.Kindly take note of the same.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,We have received intimation from our shareholder regarding loss of share certificate, as detailed in enclosed letter. Request you to kindly take note of the same.
Procter & Gamble Health Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
| AnnouncementDear Sir,Please find attached report received from RTA confirming compliance under Regulation 74 of the SEBI (DP) Regulations, 2018. Kindly take the same on record.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,This is to update that we have issued duplicate share certificates to our shareholders as detailed in enclosed letter. Kindly take note of the same.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear SirPlease be informed that we have received intimation regarding loss/misplacement of share certificate by our shareholder, as detailed in enclosed letter.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear SirWe have received information regarding loss of share certificate, as detailed in enclosed letter.Please take note of the same.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,We have received information regarding loss of share certificate, as detailed in enclosed letter.Request you to kindly take note of the same.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,We have received information related to loss of share certificate, as detailed in enclosed letter. Kindly take note of the same.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,We have received information regarding loss/misplacement of share certificate from our shareholder, as detailed in enclosed letter. Request you to kindly take note of the same.
Procter & Gamble Health Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On May 2, 2024
| AnnouncementProcter & Gamble Health Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/05/2024 ,inter alia, to consider and approve We would like to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday, May 2,2024, inter alia, to consider and approve Unaudited Financial Results for the Quarter ended March 31, 2024.
Procter & Gamble Health Closure of Trading Window
| AnnouncementDear Sir,We would like to inform you that the Trading Window of the Company shall remain closed for Directors and designated employees from April 1, 2024 untill 48 hours from date of publication of unaudited financial results for the quarter ended March 31, 2024.Request you to kindly take note of the same.
Procter & Gamble Health Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
| AnnouncementDear Sir,We are informed by our Registrar Transfer Agents regarding loss/misplacement of share certificate by our shareholder, as detailed in enclosed letter. Request you to kindly take note of the same.